← Open Payments lookup

MOLLIE ROBINSON: Open Payments

NPI 1104456656 · PICAYUNE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,263 in 277 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $1,554 · 2025 $6,263

Food & beverage: $6,253Education: $10
CompanyPaymentsAmount
ABBVIE INC.98$1,431
Janssen Biotech, Inc.28$663
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$442
Takeda Pharmaceuticals U.S.A., Inc.24$415
Madrigal Pharmaceuticals4$384
Gilead Sciences, Inc.13$346
Regeneron Healthcare Solutions, Inc.10$329
Celltrion USA Inc.12$290
Ipsen Biopharmaceuticals, Inc9$282
Novo Nordisk Inc5$243

Products named: TREMFYA, RINVOQ, DUPIXENT, ENTYVIO, XIFAXAN, REZDIFFRA, SKYRIZI, LINZESS.

Industry payments across MS — which companies pay providers there.